bupropion has been researched along with Exanthem in 4 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of angioedema caused by bupropion used for smoking cessation is discussed." | 7.74 | Bupropion-induced angioedema. ( Smith, KM; Tackett, AE, 2008) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 7.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| "A case of angioedema caused by bupropion used for smoking cessation is discussed." | 3.74 | Bupropion-induced angioedema. ( Smith, KM; Tackett, AE, 2008) |
| "To report a case of bupropion-induced drug rash with eosinophilia and systemic symptoms syndrome, including acute hepatitis, obstructive lung disease, and myositis." | 3.72 | Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. ( Bagshaw, SM; Bowen, TJ; Cload, B; Gilmour, J; Leung, ST, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kluger, N | 3 |
| Jeng, YC | 1 |
| Lin, YC | 1 |
| Hsu, CK | 1 |
| Lee, JY | 1 |
| Lee, CN | 1 |
| Tackett, AE | 1 |
| Smith, KM | 1 |
| Bagshaw, SM | 1 |
| Cload, B | 1 |
| Gilmour, J | 1 |
| Leung, ST | 1 |
| Bowen, TJ | 1 |
4 other studies available for bupropion and Exanthem
| Article | Year |
|---|---|
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Psoriasis exacerbation associated with bupropion-induced exanthema.
Topics: Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Generalized pustular psoriasis caused by bupropion with rapid recurrence after self-rechallenge.
Topics: Acute Disease; Bupropion; Exanthema; Humans; Psoriasis | 2023 |
Bupropion-induced angioedema.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Angioedema; Antidepressive Agents, Second | 2008 |
Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Canada; Eosinophilia; Exanthema; Hepatit | 2003 |